Concepedia

Julie Lavolé

JL

Statistics

Publications

4

Citations

217

H-Index

4

Active since

2017

Affiliations

Inserm(Current)

Université Paris Cité

Hôpital Saint-Louis

Assistance Publique – Hôpitaux de Paris

Institut Gustave Roussy

Julie Lavolé is an author at Inserm specializing in oncology, medicine, and immunology.

Publications per year

2017–2024

4

Publications

4

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study

C. Gallois, Elisabeth Bergen, Édouard Auclin et al. · ESMO Open · 2024 · 23 citations · Full text

Medicine, Oncology, Pharmacology +11

Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition

Julie Bonnereau, Tristan Courau, Nicolas Asesio et al. · Gut · 2022 · 17 citations

Life Sciences, Immunology, Oncology +17

Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine

Khaled Alnuaimi, Julie Lavolé, Caroline Lascoux‐Combes et al. · Hepatology · 2017 · 13 citations

Medicine, Immunology, Oncology +16

1–4 of 4